Hazlett, Burt & Watson’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74K Sell
869
-177
-17% -$15.6K 0.02% 393
2026
Q2
$82K Buy
1,046
+172
+20% +$13.9K 0.02% 380
2026
Q1
$75K Sell
874
-28
-3% -$2.68K 0.02% 380
2025
Q4
$87K Buy
902
+31
+4% +$3.01K 0.03% 363
2025
Q3
$82K Buy
871
+1
+0.1% +$92 0.03% 344
2025
Q2
$76K Buy
870
+794
+1,045% +$67.3K 0.03% 320
2025
Q1
$7K Hold
76
– – ﹤0.01% 622
2024
Q4
$6K Hold
76
– – ﹤0.01% 603
2024
Q3
$7K Sell
76
-435
-85% -$36.6K ﹤0.01% 562
2024
Q2
$40K Sell
511
-199
-28% -$16.3K 0.02% 362
2024
Q1
$61K Sell
710
-31
-4% -$2.65K 0.04% 305
2023
Q4
$61K Sell
741
-200
-21% -$15.2K 0.04% 282
2023
Q3
$74K Buy
941
+51
+6% +$4.27K 0.06% 254
2023
Q2
$80K Buy
890
+55
+7% +$4.74K 0.06% 239
2023
Q1
$67K Buy
835
+313
+60% +$25.5K 0.05% 246
2022
Q4
$41K Sell
522
-1,578
-75% -$128K 0.04% 298
2022
Q3
$169K Buy
2,100
+8
+0.4% +$719 0.16% 128
2022
Q2
$188K Buy
2,092
+59
+3% +$5.98K 0.17% 122
2022
Q1
$225K Buy
+2,033
New +$215K 0.18% 116

Other funds holding MDT

Hazlett, Burt & Watson's MDT Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its Medtronic (MDT) stake by 17% in Q3 2026, selling an estimated $15.6K and leaving 869 shares worth $74K. The position accounts for 0.02% of the portfolio, ranked #393.

Hazlett, Burt & Watson first reported a position in MDT in Q1 2022 and has held it in 19 quarters since. The position peaked at $225K in Q1 2022. 1,271 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Hazlett, Burt & Watson held 869 shares of Medtronic worth $74K as of Q3 2026.
  • Hazlett, Burt & Watson sold 177 Medtronic shares in Q3 2026, an estimated $15.6K.
  • Medtronic made up 0.02% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #393 holding.
  • Hazlett, Burt & Watson first reported a position in Medtronic in Q1 2022 and has held it in 19 quarters since.
  • Hazlett, Burt & Watson's Medtronic position peaked at $225K in Q1 2022.
  • 1,271 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.